支持和抗炎饮食作为强烈的表观遗传因素在炎症性肠病
Adele Rostami1, Kristen White2, Kamran Rostami3
1Digestive Health Clinic, Palmerston North 4410, New Zealand.
World journal of gastroenterology
|August 1, 2024
概括
表观遗传学揭示了环境因素,如饮食,如何影响炎症性肠病 (IBD) 的发展和进展. 改变饮食习惯可能为IBD患者提供新的治疗策略.
科学领域:
- 环境对人类健康的影响
- 疾病的分子机制.
- 肠道微生物组和免疫力
背景情况:
- 炎症性肠病 (IBD) 源于遗传易感性和环境因素,特别是饮食之间的复杂相互作用.
- 表观遗传学提供了关于环境因素如何调节基因表达的见解,从而影响IBD的发病,预后和治疗反应.
- 全球IBD的增加与高脂肪,高糖和高添加剂的西方饮食以及久坐不动的生活方式和肥胖相关,可能促进DNA低甲基化.
研究的目的:
- 探索表观遗传学在调解环境因素对IBD的影响中的作用.
- 研究饮食干预作为IBD管理的表观遗传调节器的潜力.
- 突出饮食,肠道微生物群和IBD的炎症过程之间的联系.
主要方法:
- 审查关于IBD,表观遗传学和环境因素的当前文献.
- 对将饮食成分与表观遗传修饰 (例如DNA甲基化) 联系起来的研究进行分析.
- 检查肠道微生物群,饮食和IBD中的宿主免疫反应之间的相互作用.
主要成果:
- 环境因素,特别是饮食,显著影响表观遗传机制,如IBD中的DNA甲基化.
- 特定的饮食模式与改变基因表达和增加IBD风险有关.
- 饮食干预措施在调节表观遗传标记和改善IBD结果方面表现有前途.
结论:
- 表观遗传学提供了环境暴露,特别是饮食和IBD病原体之间的关键联系.
- 通过饮食改变准表观遗传修饰是IBD的一个有希望的治疗途径.
- 了解这些表观遗传机制可以导致新的预防和管理IBD的战略.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
01:30Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:17Irritable Bowel Syndrome I: Introduction
264
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264
01:17Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436